Last update:

Other news

Other

When health workers came up against COVID, it laid bare gaps in their training

COVID-19 turned 2020 on its head for all healthcare workers, particularly those at the front line of the pandemic response.

Other

Minorities value, perceive, and experience professionalism differently than their peers

Marginalized groups of people value professionalism more—and are more likely to leave a job at an institution due to issues of professionalism—compared to their white, male counterparts, according to a Penn Medicine study ...

Other

Accounting for 'research fatigue' in human studies

An article published in Bioethics examines the topic of research fatigue—or psychological and emotional exhaustion both towards and as a result of participating in research. The article is meant to initiate a conversation ...

Other

Do neurosurgeons face sexual harassment in their profession?

It's 2020, and as much as we wish it weren't so, sexual harassment is still with us. One need only look at social media or a steady stream of court cases: most recently, the #MeToo movement has cast a light on sexual harassment.

Other

Physicians face barriers to voting

Two new UT Southwestern studies published today report some surprising findings: Only half of practicing physicians are registered to vote, and the most common obstacle faced by resident physicians is the lack of time to ...

Other

2020 Nobel season opens with medicine prize

Breakthroughs in the field of health will be honoured Monday when the 2020 Nobel season kicks off with the medicine prize, as the world battles the worst pandemic in a century.

Other

Survey finds American support for human-animal chimera research

In September 2015, the US National Institutes of Health placed a funding moratorium on research that involves introducing human pluripotent stem cells into animal embryos—a practice that experts say is vital for advancing ...

Other

Novel educational program puts a human face on biomedical research

Translational research aims to speed research breakthroughs into the clinic. And yet, training for basic scientists and clinicians too often remains siloed, leading to divergent cultures and a loss of opportunity for cross-disciplinary ...

Other

Gilead in $21 bn deal for Immunomedics

US pharmaceutical giant Gilead Sciences confirmed Sunday that it is buying American biotech firm Immunomedics, which makes a breast cancer drug, for $21 billion.